Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Pharmacy / 藥學專業學院
  4. Clinical Pharmacy / 臨床藥學研究所
  5. Oral bisphosphonates and risk of esophageal cancer: A dose-intensity analysis in a nationwide population
 
  • Details

Oral bisphosphonates and risk of esophageal cancer: A dose-intensity analysis in a nationwide population

Resource
Cancer Epidemiol. Biomarkers Prev., 21(6), 993-995
Journal
Cancer Epidemiology Biomarkers and Prevention
Journal Volume
21
Journal Issue
6
Pages
993-995
Date Issued
2012
Author(s)
Ho, Yunn-Fang  
YUNN-FANG HO  
Lin, Jaw-Town
Wu, Chun-Ying
DOI
10.1158/1055-9965.EPI-12-0259
URI
http://www.scopus.com/inward/record.url?eid=2-s2.0-84862882948&partnerID=MN8TOARS
http://scholars.lib.ntu.edu.tw/handle/123456789/368682
Abstract
Background: Esophageal cancer has been associated with oral bisphosphonate use, but current data are conflicting and devoid of Asian studies where esophageal squamous carcinoma prevails. Methods: We assessed the association between dose intensity, stratified by use duration (observation period) and exposure frequency, of oral bisphosphonates and the risk of esophageal cancer using 16,204 esophageal cancer cases and 64,816 malignancy-free controls identified from the population-based National Health Insurance Research Database of Taiwan from 1997 to 2008. Results: Neither duration nor frequency of bisphosphonate exposures was positively correlated to esophageal cancer risk. The ORs for rare users of 1-, 3-, 5-year observation periods were 3.86, 2.58, and 2.27, respectively (P < 0.001). Similar trend of descending ORs was also observed for rare-, frequent-, and regular users of 1-year observation period (ORs = 3.86, 1.93, and 0.95, respectively). Conclusion: Our data suggest that bisphosphonates are not likely risk factors for esophageal cancer in Taiwan. Impact: The study shows no evidence of an association between bisphosphonate use and esophageal cancer risk from Asian perspective. ?2012 AACR.
SDGs

[SDGs]SDG3

Other Subjects
alendronic acid; bisphosphonic acid derivative; clodronic acid; etidronic acid; risedronic acid; article; Asian; cancer risk; controlled study; dose response; drug exposure; esophagus cancer; human; major clinical study; population research; priority journal; Taiwan; treatment duration; Carcinoma, Squamous Cell; Case-Control Studies; Diphosphonates; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Research Design; Risk Factors; Taiwan
Type
journal article
File(s)
Loading...
Thumbnail Image
Name

index.html

Size

23.18 KB

Format

HTML

Checksum

(MD5):057eac1c26ea8402445176f61868e335

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science